Showing results (1-10 of 230) with videos related to
Sort By:
Pageof 23
Microorganisms|September 28, 2023
Interferons-Implications in the Immune Response to Respiratory VirusesHarrison C Bergeron, Matthew R Hansen, Ralph A TrippExpert Opinion on Investigational Drugs|December 23, 2021
Breakthrough therapy designation of nirsevimab for the prevention of lower respiratory tract illness caused by respiratory syncytial virus infections (RSV)Harrison C Bergeron, Ralph A TrippViruses|December 28, 2021
Immunopathology of RSV: An Updated ReviewHarrison C Bergeron, Ralph A TrippMethods in Molecular Biology (Clifton, N.J.)|August 29, 2025
Quantification of Respiratory Syncytial Virus by Immunostaining Plaque AssayHarrison C Bergeron, Ralph A TrippViruses|November 11, 2022
RSV Replication, Transmission, and Disease Are Influenced by the RSV G ProteinHarrison C Bergeron, Ralph A TrippExpert Opinion on Investigational Drugs|February 26, 2020
Emerging small and large molecule therapeutics for respiratory syncytial virusHarrison C Bergeron, Ralph A TrippTherapeutic Advances in Infectious Disease|March 20, 2023
Anti-G protein antibodies targeting the RSV G protein CX3C chemokine region improve the interferon responseHarrison C Bergeron, Lawrence M Kauvar, Ralph A TrippViruses|July 27, 2024
Probenecid Inhibits Human Metapneumovirus (HMPV) Replication In Vitro and in BALB/c MiceHarrison C Bergeron, Jackelyn Crabtree, Tamas Nagy, et al.Viruses|March 6, 2021
Respiratory Syncytial Virus (RSV) G Protein Vaccines With Central Conserved Domain Mutations Induce CX3C-CX3CR1 Blocking AntibodiesHarrison C Bergeron, Jackelyn Murray, Ana M Nuñez Castrejon, et al.Vaccines|September 23, 2022
Influenza B Virus (IBV) Immune-Mediated Disease in C57BL/6 MiceHarrison C Bergeron, Zachary Beau Reneer, Aakash Arora, et al.Pageof 23